Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Affymax (AFFY) Continues Higher on OMONTYS Approval - StreetInsider.com (subscription) (blog) |
 |
 |
|
Affymax, Inc. (Nasdaq: AFFY) is showing continued strength Tuesday, following OMONTYS news issued earlier
According to a release Tuesday morning, Affymax and Takeda Pharmaceutical Company Limited, announced that OMONTYS (peginesatide) Injection is now available only for use in treating anemia due to chronic kidney disease (CKD) in adult patients on dialysis. Shares are 10.8 percent higher on the session. Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL! |
